Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.
about
Molecular magnetic resonance imaging of brain-immune interactionsNanoparticles for brain drug deliveryIron Oxide as an MRI Contrast Agent for Cell TrackingHow do immune cells support and shape the brain in health, disease, and aging?Focal transient CNS vessel leak provides a tissue niche for sequential immune cell accumulation during the asymptomatic phase of EAE induction.In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous SystemSJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigensMagnetic resonance imaging of human brain macrophage infiltrationNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesMarkers of cochlear inflammation using MRI.MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasisNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp miceImaging Neuroinflammation - from Bench to Bedside.P-glycoprotein acts as an immunomodulator during neuroinflammation.Imaging Inflammation in Cerebrovascular DiseaseMethods to assess drug permeability across the blood-brain barrier.Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a reviewMyeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model.Novel frontiers in ultra-structural and molecular MRI of the brainPathogenic implications of iron accumulation in multiple sclerosis.Simvastatin protects auditory hair cells from gentamicin-induced toxicity and activates Akt signaling in vitro.Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL /6 mice at multiple levelsIdentification of cellular infiltrates during early stages of brain inflammation with magnetic resonance microscopy.Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage modelMacrophage diversity in cardiac inflammation: a reviewPresence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogsAstragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levelsContinued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitorDNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in Neuroinflammation Multiple Sclerosis ModelCyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation.Antioxidants and polyunsaturated fatty acids in multiple sclerosis.Visualizing brain inflammation with a shingled-leg radio-frequency head probe for 19F/1H MRI.Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.Disease Modifying Therapy in Multiple Sclerosis.
P2860
Q21129471-BBC8DE40-2F17-442D-A228-8A2849349B9AQ21285117-B18FFD60-70D9-4962-AE15-DFAB6757F061Q26781657-1E88074C-BD1E-4930-9F25-19705CEE22ADQ26995364-180B8EB7-3A81-480C-8495-FF18D7467F84Q27311399-EAEF1528-AED3-4EB8-B182-EDB12642DC97Q27313901-0D9B74FB-7D9C-42C4-8936-45335A181262Q27325607-00FD2EB1-D2E0-468E-A346-9D5BBF6DFAB7Q28307827-3595DE6E-BEA2-44F1-871A-692404C3DC38Q28546214-4D0262E1-AB13-4067-9B19-9EA3A63319A2Q30442598-D7D4FD69-1EBF-44A9-891C-C1513BD3F56EQ30542941-20AC7FD5-F077-413D-A299-5318F13E6D1EQ30576477-9D210499-46BD-4075-A0C4-80CC32B75973Q30583221-74600FB6-29B8-403F-A6F9-BDF6BDC56147Q30831649-B280A73B-9CEC-4F37-8633-5F2B25AD46E2Q30840308-9CD7C5EA-F654-48FB-8AC9-E26B14D2830DQ30881154-9BB86253-363A-42D9-A8E1-0CE516119078Q30973736-35DE45F7-5795-46F2-B6C3-B9477F50D68AQ30992289-F3FEDB93-08F1-4BEA-87F3-9EB695C5571EQ31034258-B4104333-D37D-4A96-BAAD-957C5D65D251Q33503551-DE22E889-AD60-47F4-9ED9-2F4538E3DEACQ33708751-21C9FD35-F712-4269-9AD0-3A02CBECCD23Q33943399-9B8589EB-BA37-4919-8C36-F1B4C3372016Q33953354-DC33F2E9-B765-42EE-A95D-6B11F09F9DF1Q34049616-EFBA758E-55BA-4860-BBDB-7A5D6AB0607BQ34074205-EF132E28-C462-4456-AA6A-F8D6D7DB0CCEQ34136051-D38F1755-2288-4F5C-8867-BC7C62AE8283Q34200068-5416460D-9505-4FB3-9ECC-CA916BA6B695Q34520694-DF49A9CC-7424-4EA9-A151-97415FA43414Q34937306-C9A43E67-A4F9-4E1C-AE20-A1127D78B57BQ34999794-6A1FC1C1-A5FF-4FD7-B83C-53C69EE69454Q35016996-9DBDF7D3-2B0D-4447-A639-29D35CE8725BQ35221952-04EC9227-E62E-4A15-93E4-D5E16473D9C9Q35718387-4F6A84F9-8F6D-48FE-B467-28B2A1DE5805Q35936655-55057DC5-DD27-4A62-BDB7-CDF2F73D6DC1Q36067379-E3945E20-7E75-4297-8CB0-0936F1E23825Q36173387-EFD69196-6807-4E6D-BF82-D80283416ED2Q36239170-A71FB84E-FAAF-4C67-B1D6-1270A1E7CA01Q36612391-C3ABD6B7-1981-41CF-A4CE-50D8E6C40ADBQ36926813-E7AB56E3-B035-47F4-8CCE-56EB309FE1A0Q36979819-87D2B8F0-6588-4C10-80F0-13F2152220E2
P2860
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@en
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@nl
type
label
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@en
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@nl
prefLabel
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@en
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@nl
P2093
P50
P356
P1433
P1476
Blood-brain barrier permeabili ...... tis: a quantitative MRI study.
@en
P2093
C D Dijkstra
H E de Vries
I L Schadee-Eestermans
S M A van der Pol
P304
P356
10.1093/BRAIN/AWH068
P407
P577
2003-12-22T00:00:00Z